IVGN Insider Trading Activity and SEC Form 4 Filings
IVGN insider trading summary
No open-market insider purchases or sales of Invitrogen Corp (IVGN) have been reported on SEC Form 4 in the past 12 months.
Latest IVGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 18, 2008 | Ronald A Matricaria | Director | Buy | $289K (11,700 @ $24.69) |
| Nov 17, 2008 | Ronald A Matricaria | Director | Buy | $20K (800 @ $24.65) |
| Nov 17, 2008 | Ronald A Matricaria | Director | Buy | $62K (2,500 @ $24.72) |
| Nov 17, 2008 | Ronald A Matricaria | Director | Buy | $63K (2,500 @ $25.00) |
| Nov 17, 2008 | Ronald A Matricaria | Director | Buy | $61K (2,500 @ $24.50) |
| Nov 17, 2008 | Ronald A Matricaria | Director | Buy | $205K (8,300 @ $24.75) |
| Nov 17, 2008 | Ronald A Matricaria | Director | Buy | $42K (1,700 @ $24.65) |
| Nov 14, 2008 | Gregory T Lucier | CEO | Buy | $999K (37,800 @ $26.42) |
| Nov 14, 2008 | Ronald A Matricaria | Director | Buy | $262K (10,000 @ $26.24) |
| May 15, 2008 | Bernd Brust | SVP, Worldwide Sales | Sell | $9K (100 @ $92.98) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.